Role of Repeat Resection in Non–Muscle-Invasive Bladder Cancer

Restricted access

Repeat transurethral resection (TUR) is indicated for high-grade non–muscle-invasive bladder tumors. Repeat TUR is a diagnostic, therapeutic, prognostic, and predictive procedure. Repeat TUR achieves optimal local control by removing residual tumors after initial TUR, improves staging accuracy, provides additional histologic material favoring accurate diagnosis, allocates appropriate therapy with improved outcomes, facilitates response to intravesical therapy, and provides important prognostic information.

Correspondence: Harry W. Herr, MD, Memorial Sloan Kettering Cancer Center, 353 East 68th Street, New York, NY 10065. E-mail: herrh@mskcc.org
  • 1.

    HerrHWDonatSM. Quality control in transurethral resection of bladder tumors. BJUI2008;102:12421246.

  • 2.

    ClarkPESpeissPEAgarwalN. NCCN Clinical Practice Guidelines in Oncology: Bladder Cancer. Version 2 2015. Available at: NCCN.org. Accessed July 15 2015.

    • Search Google Scholar
    • Export Citation
  • 3.

    MaruniakNATakezawaKMurphyWM. Accurate pathologic staging of urothelial neoplasms requires better cystoscopic sampling. J Urol2002;167:24042407.

    • Search Google Scholar
    • Export Citation
  • 4.

    ZurkirchenMASulserTGaspertAHauriD. Second TUR of superficial transitional cell carcinoma of the bladder: a must even for experienced urologists. Urol Int2004;72:99102.

    • Search Google Scholar
    • Export Citation
  • 5.

    DalbagniGHerrHWReuterVE. Impact of a second transurethral resection on staging of T1 bladder cancer. Urology2002;60:822825.

  • 6.

    PychaAl. How to teach the teacher to teach the TUR-B. Int J Surg2007;5:8185.

  • 7.

    RichardsKASmithNDSteinbergGD. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies. J Urol2014;191:16551664.

    • Search Google Scholar
    • Export Citation
  • 8.

    HerrHW. Role of re-resection in non-muscle-invasive bladder cancer. ScientificWorldJournal2011;11:283288.

  • 9.

    VianelloACostantiniEDel ZingaroM. Repeated white light transurethral resection of the bladder in nonmuscle-invasive urothelial bladder cancers: systematic review and meta-analysis. J Endourol2011;25:17031712.

    • Search Google Scholar
    • Export Citation
  • 10.

    GuevaraASalomonLAlloryY. The role of tumor-free status in repeat resection before intravesical BCG for high grade Ta,T1 and CIS bladder cancer. J Urol2010;183:21612164.

    • Search Google Scholar
    • Export Citation
  • 11.

    DivrikRTSahinAFYildirimU. Impact of routine second TUR on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomized clinical trial. Eur Urol2010;58:185190.

    • Search Google Scholar
    • Export Citation
  • 12.

    SfakianosJPKimPHHerrHW. The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical BCG. J Urol2013;191:341345.

    • Search Google Scholar
    • Export Citation
  • 13.

    DalbagniGVoraKKaagM. Clinical outcome in a contemporary series of restaged patients with T1 bladder cancer. Eur Urol2009;56:903910.

  • 14.

    HerrHWDonatSMDalbagniG. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?J Urol2007;177:7579.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 66 66 9
PDF Downloads 26 26 8
EPUB Downloads 0 0 0